XML 85 R75.htm IDEA: XBRL DOCUMENT v3.24.3
Segments - Schedule of Revenues by Major Products and Activities (Detail) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Product Information [Line Items]        
Revenues $ 4,332 $ 3,850 $ 12,315 $ 11,389
Europe [Member]        
Product Information [Line Items]        
Revenues 1,265 1,146 3,749 3,493
International Markets [Member]        
Product Information [Line Items]        
Revenues 613 591 1,802 1,750
United States [Member]        
Product Information [Line Items]        
Revenues 2,225 1,896 6,060 5,465
Generic products [Member] | Europe [Member]        
Product Information [Line Items]        
Revenues 973 886 2,947 2,727
Generic products [Member] | International Markets [Member]        
Product Information [Line Items]        
Revenues 477 470 1,440 1,425
Generic products [Member] | United States [Member]        
Product Information [Line Items]        
Revenues 1,094 839 2,924 2,471
AJOVY [Member] | Europe [Member]        
Product Information [Line Items]        
Revenues 56 41 158 115
AJOVY [Member] | International Markets [Member]        
Product Information [Line Items]        
Revenues 24 18 63 45
AJOVY [Member] | United States [Member]        
Product Information [Line Items]        
Revenues 58 56 144 154
AUSTEDO [Member] | United States [Member]        
Product Information [Line Items]        
Revenues 435 339 1,124 817
BENDEKA and TREANDA [Member] | United States [Member]        
Product Information [Line Items]        
Revenues 40 56 127 185
COPAXONE [Member] | Europe [Member]        
Product Information [Line Items]        
Revenues 53 55 163 174
COPAXONE [Member] | International Markets [Member]        
Product Information [Line Items]        
Revenues 13 16 38 50
COPAXONE [Member] | United States [Member]        
Product Information [Line Items]        
Revenues 69 98 179 224
UZEDY [Member] | United States [Member]        
Product Information [Line Items]        
Revenues 35 2 75 14
Anda [Member] | United States [Member]        
Product Information [Line Items]        
Revenues 380 367 1,134 1,183
Respiratory Product [Member] | Europe [Member]        
Product Information [Line Items]        
Revenues 60 61 183 195
Other [Member] | Europe [Member]        
Product Information [Line Items]        
Revenues 124 [1] 104 [1] 299 [2] 282 [2]
Other [Member] | International Markets [Member]        
Product Information [Line Items]        
Revenues 99 [1] 87 [1] 261 [2] 229 [2]
Other [Member] | United States [Member]        
Product Information [Line Items]        
Revenues $ 115 $ 140 $ 352 $ 417
[1] Other revenues in the third quarter of 2024 include the sale of certain product rights.
[2] Other revenues in the first nine months of 2024 include the sale of certain product rights.